AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 116 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $15,559,500,000 | -25.8% | 553,916 | 0.0% | 6.02% | -1.5% |
| Q2 2019 | $20,971,260,000 | -33.1% | 553,916 | -31.0% | 6.11% | -40.8% |
| Q1 2019 | $31,337,196,000 | +22.0% | 803,106 | -33.3% | 10.32% | -18.8% |
| Q4 2018 | $25,682,392,000 | -46.1% | 1,204,615 | 0.0% | 12.71% | -21.6% |
| Q3 2018 | $47,690,708,000 | +3.6% | 1,204,615 | 0.0% | 16.22% | +13.0% |
| Q2 2018 | $46,028,339,000 | +27.2% | 1,204,615 | 0.0% | 14.36% | +24.0% |
| Q1 2018 | $36,198,681,000 | -3.8% | 1,204,615 | 0.0% | 11.58% | -70.8% |
| Q4 2017 | $37,644,219,000 | -26.0% | 1,204,615 | -33.3% | 39.61% | +2.3% |
| Q3 2017 | $50,862,321,000 | +47.1% | 1,806,832 | 0.0% | 38.71% | +42.3% |
| Q2 2017 | $34,582,764,000 | +12.3% | 1,806,832 | 0.0% | 27.20% | +21.5% |
| Q1 2017 | $30,788,417,000 | -6.7% | 1,806,832 | 0.0% | 22.39% | -30.3% |
| Q4 2016 | $33,010,821,000 | +2.6% | 1,806,832 | 0.0% | 32.13% | -10.4% |
| Q3 2016 | $32,179,678,000 | – | 1,806,832 | – | 35.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |